TEMOZOLOMIDE
NDC 16571-821, temozolomide, capsule, from Rising Pharma Holdings, Inc..
- Product NDC
- 16571-821
- Status
- Listed
- Labeler
- Rising Pharma Holdings, Inc.
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA206309
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/16571-821 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TEMOZOLOMIDE250 mg/1
Pharmacologic classes
Alkylating Activity [MoA]; Alkylating Drug [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 16571-821-02 | 16571082102 | 20 CAPSULE in 1 BOTTLE (16571-821-02) |
| 16571-821-51 | 16571082151 | 5 CAPSULE in 1 BOTTLE (16571-821-51) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/70996a9d-4a4f-4ed1-ab07-130486aa14ab
Use it
Look up 16571-821 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/16571-821 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 16571-821. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.